Cory Davidson
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Ultragenyx Pharmaceutical Inc. accounts for 82.2% of it on its own, with 45 other manufacturers making up the rest. Reporting peaked in 2022 at $73,518 and has fallen 99.8% since, to $179 in 2025. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 655 payments — averaging $182.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ultragenyx Pharmaceutical Inc.$98K
- Kyowa Kirin, Inc.$12K
- AbbVie$3K
- Novo Nordisk$2K
- Dexcom, Inc.$803
- Lilly USA, LLC$635
- plus $3K from 40 others
What the payments were for
- Consulting fees$57,29048%
- Speaking & faculty fees$20,23017%
- Travel & lodging$30,60626%
- Food & beverage$11,2439%
- Education$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRYSVITA$91,501
- Synthroid$2,100
- NATPARA (PARATHYROID HORMONE)$125
- DEXCOM G6 TRANSMITTER$125
- Ozempic$122
- t:slim X2 Insulin Pump with Control-IQ$112
- RYBELSUS$101
How this compares
$119,481 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 38 | $34,837 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $19,209 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 17 | $13,598 |
| MounjaroTirzepatide | 11 | $11,055 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $6,429 |
| SynthroidLevothyroxine Sodium | 61 | $4,491 |
| Novolog FlexpenInsulin Aspart | 15 | $3,792 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $3,367 |
| HumalogInsulin Lispro | 11 | $2,047 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 13 | $1,505 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 14 | $1,179 |
| Metformin Hcl ErMetformin Hcl | 31 | $896 |
| Rosuvastatin Calcium | 20 | $476 |
| Levothyroxine Sodium | 47 | $432 |
| Metformin Hcl | 33 | $245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $96 | $34,83738 claims |
| Lilly USA, LLCMounjaro, Humalog | $635 | $13,10222 claims |
| AbbVieSynthroid | $2,523 | $4,49161 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $75 | $43247 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Erie
- Emily ScavellaErie$13K
- Amy DudasErie$12K
- Jacqueline KernaghanSpringfield$426K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.